COLLINS HELEN LOUISE (CHIEF MEDICAL OFFICER) sold 16.7% of their position (5K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $192.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/21/2026ACC: 0001701247-26-000014
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
-5K
Net shares
Net seller
$192.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$2.48
Trade value
$12.40K
% of position
20.0%
10/19/2026
25K→30K
Common Stock
Direct
Shares
−5K
Price / share
$38.47
Trade value
$192.34K
% of position
16.7%
10/19/2026
30K→25K
Total
Net shares
+0.00
Net value
-$179.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/19/2026 | M · Option Exercise | +5K | $2.48 | $12.40K | 20.0% | 25K | 30K |
| Common Stock Direct | 10/19/2026 | S · Sale | −5K | $38.47 | $192.34K | 16.7% | 30K | 25K |
| Total | +0.00 | -$179.94K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
2.48
Held after
101.27K
Exercisable
—
10/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5K shares | 10/19/2026 | M · Option Exercise | −5K | 2.48 | — | 101.27K |